Skip to main content

1 December 2022

Last updated: Tuesday 29 November 2022

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

The Case for HTA co-operation

Monday 12 May 2014

Interviewee/Contributor

Richard C. Ascroft et al

Organisation

Eli Lilly and Company

Organisations

NDA Regulatory Science Ltd
Mission Therapeutics
Acesion Pharma ApS
Arecor Therapeutics Plc
ImmunoGen Inc
Stem Cells for Safer Medicines Ltd
BC Platforms AG
Independent regulatory affairs professional
Karus Therapeutics Ltd
MaaT Pharma SA

Interviewees and Contributers

Frank Carr
Patrik De Haes
Michael L Roberts
Christophe Bonny
Jane Buus Laursen
Marisa Papaluca-Amati
Tara Raveendran
Emma Dabbs
Erik Manting
John Lisman

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Frank Mathias appointed CEO of Oxford Biomedica

Sunday 27 November 2022

Grünenthal appoints chief commercial officer

Sunday 27 November 2022

Richard Bungay joins Imophoron as CEO

Saturday 19 November 2022

Dipal Patel joins Valneva as chief commercial officer

Saturday 19 November 2022

Bo Jesper Hansen nominated as Sobi chair

Saturday 19 November 2022

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2022 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form